Reuters logo
BRIEF-AmpliPhi Biosciences announces positive feedback from FDA on phase 2 development proposal
2017年4月17日 / 下午1点07分 / 5 个月前

BRIEF-AmpliPhi Biosciences announces positive feedback from FDA on phase 2 development proposal

April 17 (Reuters) - AmpliPhi Biosciences Corp

* AmpliPhi Biosciences announces positive feedback from FDA on phase 2 development proposal

* AmpliPhi Biosciences Corp - begins formal review of strategic options

* AmpliPhi Biosciences - FDA provided positive feedback on development proposal to commence phase 2 trial with proprietary Bacteriophage cocktail ab-sa01

* AmpliPhi biosciences - company has retained H.C. Wainwright & Co., LLC to advise co and its board of directors in review of strategic alternatives Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below